http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009507809-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-10
filingDate 2006-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009507809-A
titleOfInvention Crystal form of 1-chloro-4- (β-D-glucopyranos-1-yl) -2- (4-ethynyl-benzyl) -benzene, process for its preparation and their use for the manufacture of a medicament
abstract The present invention relates to crystalline hydrates of 1-chloro-4- (β-D-glucopyranos-1-yl) -2- (4-ethynyl-benzyl) -benzene and 1-chloro-4- (β-D- The present invention relates to crystalline complexes of glucopyranos-1-yl) -2- (4-ethynyl-benzyl) -benzene and natural amino acids, methods for their preparation, and their use for pharmaceutical production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015522644-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016540790-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018090606-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013528190-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019517575-A
priorityDate 2005-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004536047-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4181605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003114390-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64522
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID539084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454192538
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID252854
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6524
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246787
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID115584
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID233836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161895619
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399680
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34117

Total number of triples: 52.